Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
 
Search Article 
  
Advanced search 
  Users Online: 2143 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
This article has been cited by
1Cabergoline in acromegaly
Emmanuelle Kuhn,Philippe Chanson
Pituitary.2017;20(1)121
[DOI]
2Cabergoline use and risk of fibrosis and insufficiency of cardiac valves
R. De Vecchis,C. Esposito,C. Ariano
Herz.2013;38(8)868
[DOI]
3Cabergoline use and risk of fibrosis and insufficiency of cardiac valves
Philippe Chanson,Dominique Maiter
Herz.2017;38(8)467
[DOI]
4The Third Case of Cabergoline-Associated Valvulopathy: The Value of Routine Cardiovascular Examination for Screening
Carmela Caputo,David Prior,Warrick J Inder
Journal of the Endocrine Society.2018;2(8)965
[DOI]
5The need for annual echocardiography to detect cabergoline-associated valvulopathy in patients with prolactinoma: a systematic review and additional clinical data
Carmela Caputo,David Prior,Warrick J Inder
The Lancet Diabetes & Endocrinology.2015;3(11)906
[DOI]
  Feedback 
  Subscribe 

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal